References
- Auger C, Teissedre PL, Gerain P, Lequeux N, Bornet A, Serisier S, Besancon P, Caporiccio B, Cristol JP, Rouanet JM. Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation. Journal of Agricultural and Food Chemistry 2005; 53: 2015–2021
- Benito S, Buxaderas S, Mitjavila MT. Flavonoid metabolites and susceptibility of rat lipoproteins to oxidation. American Journal of Physiology. Heart and circulation physiology 2004; 287: H2819–H2824
- Boersma MG, Van derWoude H, Bogaards J, Boeren S, Vervoort J, Cnubben NH, Van Iersel ML, Van Bladeren PJ, Rietjens IM. Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases. Chemical Research in Toxicology 2002; 15: 662–670
- Chen YK, Li X, Chen SQ, Zeng S. Heterologous expression of active human uridine diphosphate glucuronosyltransferase 1A3 in Chinese hamster lung cells. World Journal of Gastroenterology 2005; 11: 118–121
- Cheng ZQ, Radominska-Pandya A, Tephly TR. Cloning and expression of human UDP-glucuronosyltransferase (UGT) 1A8. Archives of Biochemistry and Biophysics 1998; 356: 301–305
- Cheng ZQ, Radominska-Pandya A, Tephly TR. Studies on the substrate specificity of human intestinal UDP-glucuronosyltransferases 1A8 and 1A10. Drug Metabolism and Disposition 1999; 27: 1165–1170
- Choi JA, Kim JY, Lee JY, Kang CM, Kwon HJ, Yoo YD, Kim TW, Lee YS, Lee SJ. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. International Journal of Oncology 2001; 19: 837–844
- Day AJ, Bao Y, Morgan MR, Williamson G. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radical Biology and Medicine 2000; 29: 1234–1243
- Green MD, King CD, Mojarrabi B, Mackenzie PI, Tephly TR. Glucuronidation of amines and other xenobiotics catalysed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metabolism and Disposition 1998; 26: 507–512
- Janisch KM, Williamson G, Needs P, Plumb GW. Properties of quercetin conjugates: Modulation of LDL oxidation and binding to human serum albumin. Free Radical Research 2004; 38: 877–884
- Jones DJ, Lamb JH, Verschoyle RD, Howells LM, Butterworth M, Lim CK, Ferry D, Farmer PB, Gescher AJ. Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity. British Journal of Cancer 2004; 91: 1213–1219
- Li XM, Li X, Chen SQ, Zeng S. Construction of pcDNA3. 1-UDPGT1A9 expression plasmid and establishment of its transgenic cell line. Chinese Journal of Pharmacology and Toxicology 2004; 8: 115–120
- Miners JO, Smith PA, Sorich MJ, McKinnon RA, Mackenzie PI. Predicting human drug glucuronidation parameters: Application of in vitro and in silico modeling approaches. Annual Review of Pharmacology and Toxicology 2004; 44: 1–25
- Moon JH, Tsushida T, Nakahara K, Terao J. Identification of quercetin 3-O-beta-D-glucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin. Free Radical Biology and Medicine 2001; 30: 1274–1285
- Morand C, Crespy V, Manach C, Besson C, Demigne C, Remesy C. Plasma metabolites of quercetin and their antioxidant properties. American Journal of Physiology 1998; 275: R212–R219
- Morikawa K, Nonaka M, Narahara M, Torii I, Kawaguchi K, Yoshikawa T, Kumazawa Y, Morikawa S. Inhibitory effect of quercetin on carrageenan-induced inflammation in rats. Life Sciences 2003; 74: 709–721
- O'Leary KA, Day AJ, Needs PW, Sly WS, O'Brien NM, Williamson G. Flavonoid glucuronides are substrates for human liver beta-glucuronidase. FEBS Letters 2001; 503: 103–106
- Oliveira EJ, Watson DG. In vitro glucuronidation of kaempferol and quercetin by human UGT-1A9 microsomes. FEBS Letters 2000; 471: 1–6
- Qian MR, Chen SQ, Li X, Zeng S. Cloning and expression of human UDP-glucuronosyltransferase 1A4 in Bac-to-Bac system. Biochemical and Biophysical Research Communications 2004; 319: 386–392
- Silva MM, Santos MR, Caroco G, Rocha R, Justino G, Mira L. Structure–antioxidant activity relationships of flavonoids: A re-examination. Free Radical Research 2002; 36: 1219–1227
- Singh A, Naidu PS, Kulkarni SK. Reversal of aging and chronic ethanol-induced cognitive dysfunction by quercetin a bioflavonoid. Free Radical Research 2003; 37: 1245–1252
- Spencer JP, Chowrimootoo G, Choudhury G, Debnam ES, Srai SK, Rice-Evans C. The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Letters 1999; 458: 224–230
- Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. American Journal of Clinical Nutrition 2005; 81: 243S–255S
- Wittig J, Herderich M, Graefe EU, Veit M. Identification of quercetin glucuronides in human plasma by high-performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography B, Biomedical Sciences and Applications 2001; 753: 237–243
- UV spectra of flavone and flavonol. The manual for identification of flavonoids, RS Xu, BN Zhou, BP Ying, JS Liu, XG He, GW Qin, GF Zeng. Science, Beijing 1981; 399–517
- Yamamoto N, Moon JH, Tsushida T, Nagao A, Terao J. Inhibitory effect of quercetin metabolites and their related derivatives on copper ion-induced lipid peroxidation in human low-density lipoprotein. Archives of Biochemistry and Biophysics 1999; 372: 347–354
- Yoshizumi M, Tsuchiya K, Suzaki Y, Kirima K, Kyaw M, Moon JH, Terao J, Tamaki T. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochemical and Biophysical Research Communications 2002; 293: 1458–1465
- Zheng SL, Qian MR, Li X, Chen SQ, Zeng S. Expression of human UGT1A6 in insect cell with baculovirus expression system. Chinese Journal of Pharmacology and Toxicology 2004; 18: 444–448